EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Noninvasive detection of microsatellite instability in patients with endometrial cancer

Carlos Casas-Arozamena iD, Cristian Pablo Moiola iD, Ana Vilar, Marta Bouso, Juan Cueva, Silvia Cabrera, Victoria Sampayo, Efigenia Arias, Alicia Abalo iD, Ángel García, Ramón Manuel Lago-Lestón, Sara Oltra iD und 8 weitere

International Journal of Cancer · 15.05.2023 · 152 (10) · 2206-2217

DOI: 10.1002/ijc.34435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 24.01.2023. Verfasst von Carlos Casas-Arozamena und 19 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compos…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centro de Investigación Biomédica en Red de Cáncer, Fundación Científica Asociación Española Contra el Cáncer, Fundación Instituto de Investigación Sanitaria de Santiago de Compostela.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The analysis of mismatch repair proteins in solid tissue is the standard of care (SoC) for the microsatellite instability (MSI) characterization in endometrial cancer (EC). Uterine aspirates (UAs) or circulating‐DNA (cfDNA) samples capture the intratumor heterogeneity and provide a more comprehensive and dynamic molecular diagnosis. Thus, MSI analysis by droplet‐digital PCR (ddPCR) in UAs and cfDNA can provide a reliable tool to characterize and follow‐up the disease. The UAs, paraffin‐embedded tumor tissue (FFPE) and longitudinal plasma samples from a cohort of 90 EC patients were analyzed using ddPCR panel and compared to the SoC. A high concordance (96.67%) was obtained between the analysis of MSI markers in UAs and the SoC. Three discordant cases were validated as unstable by ddPCR on FFPE samples. Besides, a good overall concordance (70.27%) was obtained when comparing the performance of the ddPCR assay on UAs and cfDNA in high‐risk tumors. Importantly, our results also evidenced the value of MSI analysis to monitor the disease evolution. MSI evaluation in minimally invasive samples shows great accuracy and sensitivity and provides a valuable tool for the molecular characterization and follow‐up of endometrial tumors, opening new opportunities for personalized management of EC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsCell-Free Nucleic AcidsFemaleHumansMicrosatellite InstabilityMicrosatellite RepeatsPolymerase Chain Reaction

Stichwörter der Autor:innen

cfDNActDNAdisease monitoringendometrial cancerliquid biopsymicrosatellite instabilityuterine aspirate

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.
  • Department of Medicine, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.
  • Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Gynecology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.
  • Pathology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.
  • Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.

ORCID-Profile: Carlos Casas-Arozamena, Cristian Pablo Moiola, Alicia Abalo, Sara Oltra, Juan Ruiz-Bañobre, Rafael López-López, Gema Moreno-Bueno, Antonio Gil-Moreno, Eva Colás, Miguel Abal, Laura Muinelo-Romay

Förderung

  • Centro de Investigación Biomédica en Red de Cáncer
  • Fundación Científica Asociación Española Contra el Cáncer
  • Fundación Instituto de Investigación Sanitaria de Santiago de Compostela

Zitieren

APA

Casas-Arozamena, C., Moiola, C. P., Vilar, A., Bouso, M., Cueva, J., Cabrera, S., Sampayo, V., Arias, E., Abalo, A., García, Á., Lago-Lestón, R. M., Oltra, S., Díaz, E., Ruiz-Bañobre, J., López-López, R., Moreno-Bueno, G., Gil-Moreno, A., Colás, E., Abal, M., & Muinelo-Romay, L. (2023). Noninvasive detection of microsatellite instability in patients with endometrial cancer. International Journal of Cancer, 152(10), 2206-2217. https://doi.org/10.1002/ijc.34435

Vancouver

Casas-Arozamena C, Moiola CP, Vilar A, Bouso M, Cueva J, Cabrera S, et al. Noninvasive detection of microsatellite instability in patients with endometrial cancer. International Journal of Cancer. 2023;152(10):2206-2217. doi:10.1002/ijc.34435

BibTeX
@article{CasasArozamena2023,
  author = {Casas-Arozamena, Carlos and Moiola, Cristian Pablo and Vilar, Ana and Bouso, Marta and Cueva, Juan and Cabrera, Silvia and Sampayo, Victoria and Arias, Efigenia and Abalo, Alicia and García, Ángel and Lago-Lestón, Ramón Manuel and Oltra, Sara and Díaz, Eva and Ruiz-Bañobre, Juan and López-López, Rafael and Moreno-Bueno, Gema and Gil-Moreno, Antonio and Colás, Eva and Abal, Miguel and Muinelo-Romay, Laura},
  title = {Noninvasive detection of microsatellite instability in patients with endometrial cancer},
  journal = {International Journal of Cancer},
  year = {2023},
  volume = {152},
  number = {10},
  pages = {2206--2217},
  doi = {10.1002/ijc.34435}
}
Kostenlos starten →